Corifollitropin Alfa Versus Follitropin Beta in High Responders
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this randomized controlled trial (RCT) is to compare a single injection of
corifollitropin-alfa versus daily injections of follitropin beta regarding the number of
oocytes retrieved, hormonal profile and follicle development in patients with high response
undergoing ovarian stimulation for in vitro fertilization treatment using a
gonadotropin-releasing hormone (GnRH) antagonist protocol combined with GnRH agonist trigger
and cryopreservation of all embryos.